Alyn Hugh Morice (Alyn H Morice, Alyn Morice, A H Morice)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 36

Top Topics

Chronic Obstructive Pulmonary Disease

Top Venues

ERJ open research

NPJ primary care respiratory medicine

American journal of respiratory and critical care medicine

This page only lists publications with an associated author ORCID identifier.

Publications

M G Crooks, H Cummings, Alyn Hugh Morice, D Sykes, S Brooks, A Jackson, Y Xu
Reducing short-acting beta-agonist use in asthma: Impact of national incentives on prescribing practices in England and the findings from SENTINEL Plus early adopter sites. NPJ primary care respiratory medicine 34 (1) (2024)
M G Crooks, H Cummings, Alyn Hugh Morice, D Sykes, S Brooks, A Jackson, Y Xu
Reducing short-acting beta-agonist use in asthma: Impact of national incentives on prescribing practices in England and the findings from SENTINEL Plus early adopter sites. NPJ primary care respiratory medicine 34 (1) (2024)
M G Crooks, H Cummings, Alyn Hugh Morice, D Sykes, S Brooks, A Jackson, Y Xu
Reducing short-acting beta-agonist use in asthma: Impact of national incentives on prescribing practices in England and the findings from SENTINEL Plus early adopter sites. NPJ primary care respiratory medicine 34 (1) (2024)
Mengru Zhang, Alyn Hugh Morice
Correspondence Regarding Lee et al.: Placebo Control is Vital in Assessing Therapy in Chronic Cough. Lung (2024)
M G Crooks, H Cummings, Alyn Hugh Morice, D Sykes, S Brooks, A Jackson, Y Xu
Reducing short-acting beta-agonist use in asthma: Impact of national incentives on prescribing practices in England and the findings from SENTINEL Plus early adopter sites. NPJ primary care respiratory medicine 34 (1) (2024)
Alyn Hugh Morice
A survey of UK respiratory specialists' opinion on the management of chronic cough. ERJ open research 10 (4) (2024)
M G Crooks, H Cummings, Alyn Hugh Morice, D Sykes, S Brooks, A Jackson, Y Xu
Author Correction: Reducing short-acting beta-agonist use in asthma: Impact of national incentives on prescribing practices in England and the findings from SENTINEL Plus early adopter sites. NPJ primary care respiratory medicine 34 (1) (2024)
Mengru Zhang, Alyn Hugh Morice
Correspondence Regarding Lee et al.: Placebo Control is Vital in Assessing Therapy in Chronic Cough. Lung 202 (4) (2024)
Alyn Hugh Morice
Chronic cough: symptom, sign or disease? ERJ open research 10 (4) (2024)
Alyn Hugh Morice
A survey of UK respiratory specialists' opinion on the management of chronic cough. ERJ open research 10 (4) (2024)
Mengru Zhang, Alyn Hugh Morice
Correspondence Regarding Lee et al.: Placebo Control is Vital in Assessing Therapy in Chronic Cough. Lung 202 (4) (2024)
M G Crooks, H Cummings, Alyn Hugh Morice, D Sykes, S Brooks, A Jackson, Y Xu
Author Correction: Reducing short-acting beta-agonist use in asthma: Impact of national incentives on prescribing practices in England and the findings from SENTINEL Plus early adopter sites. NPJ primary care respiratory medicine 34 (1) (2024)
Alyn Hugh Morice
Chronic cough: symptom, sign or disease? ERJ open research 10 (4) (2024)
Michael G Crooks, Lucia Crowther, Helena Cummings, Judith Cohen, Chao Huang, Lukas Pitel, Mark Pearson, Alyn Hugh Morice, John Turgoose, Shoaib Faruqi, Michael Watt, Tamsin Morris, Yang Xu
Improving asthma care through implementation of the SENTINEL programme: findings from the pilot site. ERJ open research 9 (3) (2023)
Surinder S Birring, Alyn Hugh Morice, Peter V Dicpinigaitis, Lorcan P McGarvey, Ian D Pavord, Stuart A Green, George Philip, Jaclyn Ann Smith
Reply to: What the Placebo Tells Us about Chronic Cough. American journal of respiratory and critical care medicine (2023)
Matthew G Drake, Lorcan P McGarvey, Alyn Hugh Morice
From bench to bedside: The role of cough hypersensitivity in chronic cough. Clinical and translational medicine 13 (8) (2023)
Kayleigh Brindle, Alyn Hugh Morice, Natalie Carter, Dominic L Sykes, Mengru Zhang, Andrea Hilton
The "vicious circle" of chronic cough: the patient experience - qualitative synthesis. ERJ open research 9 (3) (2023)
Heung-Woo Park, Lieven Dupont, Surinder S Birring, Kian Fan Chung, Marta Dabrowska, Peter V Dicpinigaitis, Christian Domingo Ribas, Giovanni Fontana, Peter Gerard Gibson, Laurent Guilleminault, James Harry Hull, Marco Idzko, Peter Kardos, Hyun Jung Kim, Kefang Lai, Federico Lavorini, Eva Millqvist, Alyn Hugh Morice, Akio Niimi, Sean M Parker, Imran Satia, Jaclyn Ann Smith, Jan Willem K van den Berg, Lorcan P McGarvey
Consensus goals and standards for specialist cough clinics: the NEUROCOUGH international Delphi study. ERJ open research 9 (6) (2023)
Surinder S Birring, Peter V Dicpinigaitis, Jaclyn Ann Smith, Alyn Hugh Morice, Lorcan P McGarvey, Ian D Pavord, Allison Martin Nguyen, Jonathan Schelfhout, Qing Li, Beata Iskold, Stuart A Green, George Philip, David R Muccino, Carmen La Rosa
Efficacy and Safety of Gefapixant for Refractory or Unexplained Chronic Cough Over 52 Weeks. American journal of respiratory and critical care medicine (2023)
Kayleigh Brindle, Alyn H Morice, Natalie Carter, Alyn Hugh Morice
Subcutaneous octreotide as a therapeutic option for refractory chronic cough: subjective response pattern and adverse effects from a retrospective single-centre case series. ERJ open research 9 (3) (2023)
Lorcan McGarvey, Alyn Hugh Morice, Ashley Martin, Vicky W Li, Michael J Doane, Eduardo Urdaneta, Jonathan Schelfhout, Helen Ding, Eileen Fonseca
Burden of chronic cough in the UK: results from the 2018 National Health and Wellness Survey. ERJ open research 9 (4) (2023)
Alyn Hugh Morice
Airway disease: a confusion inside an enigma. ERJ open research 8 (4) (2022)
Christian Friedrich, Klaus Francke, Isabella Gashaw, Christian Scheerans, Stefan Klein, Lueder Fels, Jaclyn Ann Smith, Thomas Hummel, Alyn Hugh Morice
Safety, Pharmacodynamics, and Pharmacokinetics of P2X3 Receptor Antagonist Eliapixant (BAY 1817080) in Healthy Subjects: Double-Blind Randomized Study. Clinical pharmacokinetics 61 (8) (2022)
Alyn Hugh Morice
Chronic Cough in Idiopathic Pulmonary Fibrosis: The Same Difference? American journal of respiratory and critical care medicine 205 (9) (2022)
Alyn H Morice, Kayleigh Brindle, Melanie Robinson, Debbie Ingram, Tanya Cavany, Alyn Hugh Morice
Chronic cough in cystic fibrosis: the effect of modulator therapy on objective 24-h cough monitoring. ERJ open research 8 (2) (2022)
Farhad Jahanfar, Laura Sadofsky, Alyn Hugh Morice, Massimo D'Amico
Nebivolol as a Potent TRPM8 Channel Blocker: A Drug-Screening Approach through Automated Patch Clamping and Ligand-Based Virtual Screening. Membranes 12 (10) (2022)
Alyn Hugh Morice
Airway disease: a confusion inside an enigma. ERJ open research 8 (4) (2022)
Alyn Hugh Morice, Jaclyn Ann Smith, Lorcan McGarvey, Surinder S Birring, Sean M Parker, Alice Turner, Thomas Hummel, Isabella Gashaw, Lueder Fels, Stefan Klein, Klaus Francke, Christian Friedrich
Eliapixant (BAY 1817080), a P2X3 receptor antagonist, in refractory chronic cough: a randomised, placebo-controlled, crossover phase 2a study. The European respiratory journal 58 (5) (2021)
Valerie J Ludbrook, Kate E Hanrott, James L Kreindler, Joanna E Marks-Konczalik, Nick P Bird, Debbie A Hewens, Misba Beerahee, David J Behm, Alyn Hugh Morice, Lorcan McGarvey, Sean M Parker, Surinder S Birring, Jaclyn Ann Smith
Adaptive study design to assess effect of TRPV4 inhibition in patients with chronic cough. ERJ open research 7 (3) (2021)
Ji-Hyang Lee, Heung-Woo Park, Eva Millqvist, Alyn Hugh Morice
Objective cough frequency monitoring in real-world practice. ERJ open research 7 (4) (2021)
Alyn Hugh Morice, Peter V Dicpinigaitis, Lorcan McGarvey, Surinder S Birring
Chronic cough: new insights and future prospects. European respiratory review : an official journal of the European Respiratory Society 30 (162) (2021)
Alyn Hugh Morice
On Chronic Cough Diagnosis, Classification, and Treatment. Lung 199 (4) (2021)
Alyn Hugh Morice, Surinder S Birring, Jaclyn A Smith, Lorcan P McGarvey, Jonathan Schelfhout, Allison Martin Nguyen, Zhi Jin Xu, Wen-Chi Wu, David R Muccino, Mandel R Sher
Characterization of Patients With Refractory or Unexplained Chronic Cough Participating in a Phase 2 Clinical Trial of the P2X3-Receptor Antagonist Gefapixant. Lung 199 (2) (2021)
Alyn Hugh Morice
COVID-19 controversy: when to intubate? ERJ open research 7 (2) (2021)
Graham Devereux, Seonaidh Cotton, Shona Fielding, Nicola McMeekin, Peter John Barnes, Andy Briggs, Graham Burns, Rekha Chaudhuri, Henry Chrystyn, Lisa Davies, Anthony De Soyza, Simon Gompertz, John Haughney, Karen Innes, Joanna Szulc, Amanda Lee, Alyn Hugh Morice, John Dt Norrie, Anita Sullivan, Andrew M Wilson, David J Price
Low-dose oral theophylline combined with inhaled corticosteroids for people with chronic obstructive pulmonary disease and high risk of exacerbations: a RCT. Health technology assessment (Winchester, England) 23 (37) (2020)
Alyn Hugh Morice, Simon Paul Hart
Increased Propensity for Pneumonia with Fluticasone in Chronic Obstructive Pulmonary Disease. American journal of respiratory and critical care medicine 197 (9) (2019)